Blau Farmaceutica (BSP:BLAU3) FCF Margin % : 22.17% (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Blau Farmaceutica FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Blau Farmaceutica's Free Cash Flow for the three months ended in Mar. 2024 was R$80 Mil. Blau Farmaceutica's Revenue for the three months ended in Mar. 2024 was R$360 Mil. Therefore, Blau Farmaceutica's FCF Margin % for the quarter that ended in Mar. 2024 was 22.17%.

As of today, Blau Farmaceutica's current FCF Yield % is 5.58%.

The historical rank and industry rank for Blau Farmaceutica's FCF Margin % or its related term are showing as below:

BSP:BLAU3' s FCF Margin % Range Over the Past 10 Years
Min: -1.73 Med: 8.62 Max: 21.26
Current: 11.67

During the past 8 years, the highest FCF Margin % of Blau Farmaceutica was 21.26%. The lowest was -1.73%. And the median was 8.62%.

BSP:BLAU3's FCF Margin % is ranked better than
79.07% of 1027 companies
in the Drug Manufacturers industry
Industry Median: -0.2 vs BSP:BLAU3: 11.67

Blau Farmaceutica FCF Margin % Historical Data

The historical data trend for Blau Farmaceutica's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Blau Farmaceutica FCF Margin % Chart

Blau Farmaceutica Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

21.26

4.46

-1.73

9.55

7.69

Blau Farmaceutica Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Margin %	Get a 7-Day Free Trial															5.15	1.00	0.06	22.82	22.17

Competitive Comparison of Blau Farmaceutica's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Blau Farmaceutica's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Blau Farmaceutica's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Blau Farmaceutica's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Blau Farmaceutica's FCF Margin % falls into.

Blau Farmaceutica FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Blau Farmaceutica's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	105.592	/	1372.633
	=	7.69 %

Blau Farmaceutica's FCF Margin for the quarter that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	79.754	/	359.681
	=	22.17 %

Blau Farmaceutica FCF Margin % Related Terms

Thank you for viewing the detailed overview of Blau Farmaceutica's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Blau Farmaceutica (BSP:BLAU3) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Blau Farmaceutica SA (BSP:BLAU3) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Rodovia Raposo Tavares, No. 2833, Km 30.5, Barro Branco, Cotia, SP, BRA, 06705-030

Website

https://www.blau.com

Blau Farmaceutica SA is engaged in the manufacturing, development and commercialization of complex private-label drugs for the institutional segment. The Company's business activities cover institutional and retail segments, and are divided into four units: 1) Biologicals are a heterogeneous class of products that can be produced using raw materials from biological materials and biotechnological procedures. 2) Oncology line is made up of oral and injectable drugs intended for treating cancer, which encompasses a number of therapeutic classes. 3) Specialties line is made up of products that are used in the hospital's daily routine, in the specialized treatments for infectious diseases and special treatments. 4) Others consist of prescription and non-prescription over-the-counter drugs.

Blau Farmaceutica (BSP:BLAU3) Headlines

No Headlines